Skip to main content

Month: July 2020

Quotient Limited to Report First Quarter 2021 Financial Results and Host Conference Call

JERSEY, Channel Islands, July 17, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ended June 30, 2020 will be released before market open on Monday, August 3, 2020.Quotient will host a conference call to discuss its first quarter financial results at 8:00 a.m. Eastern Time the same day. Participants may access the call by dialing 1-877-407-0784 in the U.S. or 1-201-689-8560 outside the U.S. The access code is 13707267. The conference call will be webcast live on the Company’s website at www.quotientbd.com.A replay of this conference call will be available through August 10, 2020 by dialing 1-844-512-2921 in the U.S. or 1-412-317-6671 outside the U.S. The replay access code is 13707267.About Quotient LimitedBuilding...

Continue reading

Bombardier and ČD Cargo put first TRAXX MS3 locomotives into commercial trial operation in the Czech Republic

The TRAXX MS3 locomotive is the first locomotive to meet the new stringent Czech Electromagnetic Compatibility requirementsČD Cargo ordered up to 50 TRAXX MS3 locomotives for freight and passenger transport – important milestone reached with first two entering commercial operationBERLIN and PRAGUE, Czech Republic, July 17, 2020 (GLOBE NEWSWIRE) —To view the photos associated with this press release, please visit the following links:https://www.globenewswire.com/NewsRoom/AttachmentNg/d4800420-aaf4-40f6-a97b-f7be836f23b3https://www.globenewswire.com/NewsRoom/AttachmentNg/acd6c652-aded-4541-8137-302525f0fffeGlobal mobility solution provider Bombardier Transportation and ČD Cargo, a state-owned Czech railway operator, have taken an important step towards deploying BOMBARDIER TRAXX MS3 locomotives in the Czech Republic: the first two...

Continue reading

Bombardier und ČD Cargo bringen die ersten TRAXX MS3-Lokomotiven in Tschechien in den kommerziellen Probebetrieb

Die TRAXX MS3-Lokomotive ist die erste Lokomotive, die neuen strengen tschechischen Anforderungen an Elektromagnetische Verträglichkeit erfülltČD Cargo bestellte bis zu 50 TRAXX MS3 Lokomotiven für Güter- und Passagierverkehr – mit der Aufnahme des kommerziellen Probebetriebs durch die ersten beiden ist ein wichtiger Meilenstein erreichtBERLIN und PRAG, Tschechien, July 17, 2020 (GLOBE NEWSWIRE) —Fotos zu dieser Pressemitteilung finden Sie unter den folgenden Links:https://www.globenewswire.com/NewsRoom/AttachmentNg/d4800420-aaf4-40f6-a97b-f7be836f23b3https://www.globenewswire.com/NewsRoom/AttachmentNg/acd6c652-aded-4541-8137-302525f0fffeDer weltweit führende Anbieter von Mobilitätstechnologie Bombardier Transportation und ČD Cargo, ein staatseigener tschechischer Bahnbetreiber, haben einen wichtigen Schritt zum Einsatz von BOMBARDIER...

Continue reading

Vow ASA : ETIA – Vendor Notes converted to Shares

Reference is made to the notice to the stock exchange dated 15.10.19 regarding the closing of acquisition of ETIA Ecotechnologies (“ETIA”).As part of the settlement of the purchase price, Vow issued convertible loans for EUR 4 179 000, in respect of a 9 months’ seller credit. The conversion price was in Vendor Notes set to NOK 19.33 per Vow-share. The holders of the Vendor Notes have elected to receive Vow-shares, and the Board has resolved to issue 2 336 303 new shares. The share contribution in the capital increase is settled by converting the Vendor notes claims, a total of NOK 45 160 737 (exchanged from EUR to NOK).The total share capital increase in Vow is NOK 233,630.30 and the share capital of Vow will be NOK 10 889 986.90, divided into 108 899 869 shares when the capital increase has been registered in Companies’...

Continue reading

SpareBank 1 SMN: Presentation of 2nd Quarter 2020 accounts

SpareBank 1 SMN is presenting 2nd quarter 2020 financial results.Time:    Tuesday 11 August at 1:30 PM CETPlace:    WebinarPlease register by 9 August on the link below:http://epost.sparebank1.no/public/event/RegistrationForm/42455B407243475A427140The presentation will be held in Norwegian by group CEO Jan-Frode Janson and CFO Kjell Fordal.We will also host a Global Investor Webinar in English on the same day at 3:30 PM CET.Please register by 9 August on the following link:http://epost.sparebank1.no/public/event/RegistrationForm/42455B4075454A584A7440Questions to the management in relation to both presentations can be sent to investorrelations@smn.no.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

SpareBank 1 SMN: Invitasjon til resultatpresentasjon, 2. kvartal 2020

SpareBank 1 SMN inviterer til presentasjon av resultatene for 2. kvartal 2020.Tid:        Tirsdag, 11. august, kl. 13.30Sted:     WebinarPåmelding innen 9. august via følgende link:http://epost.sparebank1.no/public/event/RegistrationForm/42455B407243475A427140Presentasjonene holdes av konsernsjef Jan-Frode Janson og finansdirektør Kjell Fordal.Det vil også bli holdt et webinar på engelsk samme dag klokken 15:30.Påmelding innen 9. august her:http://epost.sparebank1.no/public/event/RegistrationForm/42455B4075454A584A7440Spørsmål til begge presentasjoner kan sendes til investorrelations@smn.no. Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Continue reading

Amicus Therapeutics Secures $400 Million Non-Dilutive Debt Financing

$400M Debt Facility Provides Path to Profitability Without the Need for Any Future Dilutive Financings Self-sustainable Financial Profile Achieved with Comprehensive, Low Cost Debt Structure and Includes Retiring Prior Term LoanCompany Reiterates 2020 Galafold Revenue of $250-$260M and 2020 Operating Expense GuidanceCRANBURY, N.J., July 17, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that it has executed a definitive agreement for a $400 million credit facility with Hayfin Capital Management (“Hayfin”). The strategic financing allows Amicus to deliver on its mission for patients and shareholders and places it firmly on a path to profitability and its vision to become...

Continue reading

Radient Technologies Inc. Announces Participation in a Medical Cannabis Study Led by the University Health Network in Partnership with Shoppers Drug Mart

EDMONTON, Alberta, July 17, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a manufacturer of high quality cannabinoid-based formulations and products, is pleased to announce that bioU products by Radient will be available to patients in the recently announced University Health Networks’ (“UHN”)  Medical Cannabis Real-World Evidence Study (“MC-RWE Study”) in partnership with Medical Cannabis by Shoppers.  The first-of-its-kind study will involve a nation-wide clinical trial to examine the effects of medical cannabis on pain, sleep and anxiety issues.Radient developed the bioU brand exclusively for Medical Cannabis by Shoppers and the products have been formulated to meet the highest levels of quality, consistency, and stability.  All three oral spray formulations currently...

Continue reading

Le Château Provides Update on Filing of Q1 Financial Statements Due to COVID-19

MONTREAL, July 17, 2020 (GLOBE NEWSWIRE) — Le Château Inc. (the “Company”) (TSX VENTURE: CTU) today provided an update on the status of the filing of its interim financial statements and management’s discussion and analysis, and related CEO and CFO certificates, for its first quarter ended April 25, 2020 (the “Q1 Documents”).On May 20, 2020, the Canadian securities administrators (“CSA”) announced that they would provide issuers with a 45-day filing extension for filings due or required to be made during the period from June 2, 2020 to August 31, 2020 to allow issuers the time needed to focus on the many other business and financial reporting implications of the COVID-19 pandemic.As previously announced on June 19, 2020, the Company is relying on the 45‑day blanket extension granted by the CSA for the filing of the Q1 Documents....

Continue reading

Le Château fait le point sur le dépôt de ses états financiers du premier trimestre en raison de la COVID-19

MONTRÉAL, 17 juill. 2020 (GLOBE NEWSWIRE) — Le Château Inc. (la « Société ») (TSXV : CTU) a fait le point aujourd’hui sur le dépôt de ses états financiers intermédiaires et de son rapport de gestion, ainsi que des attestations de la chef de la direction et de la chef des finances afférentes à ces documents, pour son premier trimestre clos le 25 avril 2020 (les « documents du T1 »).Le 20 mai 2020, les Autorités canadiennes en valeurs mobilières (« ACVM ») ont annoncé qu’elles accorderaient aux émetteurs une prolongation de 45 jours pour effectuer les dépôts requis pour la période du 2 juin 2020 au 31 août 2020 afin de leur donner le temps de se concentrer sur les nombreuses autres conséquences de la pandémie de COVID-19 sur les activités et la présentation de l’information financière.Comme il a été annoncé précédemment le 19 juin 2020,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.